Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis.
about
Interactions between smoking, pulmonary surfactant protein B, and atherosclerosis in the general population: the Dallas Heart StudyInvestigating Prevalence and Pattern of Long-term Cardiovascular Disorders in Sulphur Mustard-exposed Victims and Determining Proper Biomarkers for Early Defining, Monitoring and Analysis of Patients' Feedback on Therapy.Association of sICAM-1 and MCP-1 with coronary artery calcification in families enriched for coronary heart disease or hypertension: the NHLBI Family Heart Study.Switching α-glucosidase inhibitors to miglitol reduced glucose fluctuations and circulating cardiovascular disease risk factors in type 2 diabetic Japanese patients.Associations of four circulating chemokines with multiple atherosclerosis phenotypes in a large population-based sample: results from the dallas heart study.Chemokine ligand 2 genetic variants, serum monocyte chemoattractant protein-1 levels, and the risk of coronary artery diseaseRelationships between serum MCP-1 and subclinical kidney disease: African American-Diabetes Heart StudyTargeted cardiac expression of soluble Fas prevents the development of heart failure in mice with cardiac-specific expression of MCP-1.Effect of folic acid supplementation on levels of circulating Monocyte Chemoattractant Protein-1 and the presence of intravascular ultrasound derived virtual histology thin-cap fibroatheromas in patients with stable angina pectorisActivation of endoplasmic reticulum stress response during the development of ischemic heart disease.Baseline levels and temporal stability of 27 multiplexed serum cytokine concentrations in healthy subjects.Systemic inflammation and early atheroma formation: are they related?Serum levels of monocyte chemoattractant protein-1 and all-cause and cardiovascular mortality among patients with coronary artery disease.Systemic chemokine levels, coronary heart disease, and ischemic stroke events: the PRIME study.Obesity and inflammation: reduced cytokine expression due to resveratrol in a human in vitro model of inflamed adipose tissue.The high serum monocyte chemoattractant protein-1 in obesity is influenced by high parathyroid hormone and not adiposityRace-specific associations of myeloperoxidase with atherosclerosis in a population-based sample: the Dallas Heart StudyBiological ageing and frailty markers in breast cancer patientsEffects of a healthy life exercise program on arteriosclerosis adhesion molecules in elderly obese womenRacial Differences in Natriuretic Peptide Levels: The Dallas Heart Study.Pathophysiology and Medical Treatment of Carotid Artery Stenosis.Monocyte Chemoattractant Protein 1 (MCP-1) in obesity and diabetesInter-individual variation of inflammatory markers of cardiovascular risks and diseases.The effect of aging and caloric restriction on murine CD8+ T cell chemokine receptor gene expressionRelation of Adiponectin to All-Cause Mortality, Cardiovascular Mortality, and Major Adverse Cardiovascular Events (from the Dallas Heart Study).Biomarkers of chronic cardiac injury and hemodynamic stress identify a malignant phenotype of left ventricular hypertrophy in the general populationDysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults.Effects of human Toll-like receptor 1 polymorphisms on ageing.Formulation, characteristics and antiatherogenic bioactivities of CD36-targeted epigallocatechin gallate (EGCG)-loaded nanoparticles.Effects of an exercise challenge on mobilization and surface marker expression of monocyte subsets in individuals with normal vs. elevated blood pressure.MCP-1 binds to oxidized LDL and is carried by lipoprotein(a) in human plasma.Beyond Coronary Calcification, Family History, and C-Reactive Protein: Cholesterol Efflux Capacity and Cardiovascular Risk PredictionNon-classical monocytes predict progression of carotid artery bifurcation intima-media thickness in HIV-infected individuals on stable antiretroviral therapyGrowth factors serum levels in coronary artery disease patients scheduled for bypass surgery: perioperative dynamics and comparisons with healthy volunteers.Comparison of visceral fat mass measurement by dual-X-ray absorptiometry and magnetic resonance imaging in a multiethnic cohort: the Dallas Heart StudyAdipokines, inflammation, and visceral adiposity across the menopausal transition: a prospective study.Inflammatory and immune markers associated with physical frailty syndrome: findings from Singapore longitudinal aging studiesChlorella 11-peptide inhibits the production of macrophage-induced adhesion molecules and reduces endothelin-1 expression and endothelial permeability.Nanoencapsulation enhances epigallocatechin-3-gallate stability and its antiatherogenic bioactivities in macrophagesSex differences in the relationship between C-reactive protein and body fat.
P2860
Q28244928-193DACF4-2853-4860-A0BE-489A05551D32Q30245541-0890D1FD-B891-4869-B27E-DF497DA037A1Q33304048-9DB5A71B-8E37-402C-BB71-5A444DB45650Q34130379-B6F9EB79-2815-4FD4-85F2-D18FB4323D7AQ34163322-D87AA960-98FB-4376-A949-57045DCBF85CQ34411332-DC1CD5B7-C93F-4FC6-9627-B669B9EB7590Q34476839-AC603E7C-BC4E-4794-8567-9560D4EEF36FQ34873016-502916B6-CD28-4B79-8C9D-31BD3C3C5470Q34921979-1783BB0F-8C81-411F-ABB2-82E0D175CFE7Q35047817-5C4EE4A0-A64C-49C6-9ECD-D0A232B4B807Q35069367-6C8D2DBA-DC16-4921-A58E-2A12B92F9185Q35154761-E0159DB7-DBAC-4C39-9CA6-4020749EB8AEQ35192639-BA7A050B-4A3B-49B8-8523-72494A0C699CQ35215601-C9AA54C4-421A-416A-9AC1-45133E7842BDQ35404761-2CAD4266-D397-467D-A1B0-A03600E11D19Q35504486-F0966F05-C6A7-4013-AD48-31075D7B21D0Q35581112-1BF8E38F-88D5-4211-A625-A9EB2BE7A1C6Q35744970-82BBDE5B-1A64-4CD0-9CB4-6AAB7181B3DDQ35789994-041C1519-DC91-4B2A-8AE5-348E353C9DE7Q35842030-1B3F9498-138A-4B61-9652-995F8EBD53E8Q36065338-CA9BB3F7-C7EC-4CA5-AEA1-231A3A3F3E19Q36222092-683CAC68-9A55-416E-B15A-612C13B9FB73Q36277978-FE96CB0C-6BD3-454A-BF00-E3B185248E8EQ36384113-57932395-1F88-4750-9CA6-8D58FBD09491Q36535122-4381535A-E037-4E0D-AD5C-A5A21556886AQ36541403-55786E1A-B639-4468-A5AE-A12388BC988DQ36566370-1B399DB7-1320-4E01-A88E-692608BDA767Q36618083-3CDD7678-226C-435C-9BCD-F828E85EE15CQ36731084-6D8FEC09-0B5D-4B2D-917C-CA216C6E5EE1Q36792699-D4C58C42-9E75-4939-B547-E2BDBD28DB2AQ36920584-42131630-BD0A-4BA3-9BEB-29C86E9ABC6BQ36945110-8507153E-293D-4932-BC8C-952B9D7D662EQ36966437-F351F548-ECA9-4713-BE01-D65C071D5AB6Q37101156-B79034D5-946C-4BEA-9CE1-F0813C008E42Q37151039-5BB8DBCC-456A-4E71-887E-6D195F065E28Q37193178-B135B389-7F24-41F8-A13C-B0C991BF4F0EQ37301671-9DC3F011-6936-4F88-91C8-AF5FE58B8706Q37304014-479B618B-EC4E-4342-89FD-2E1375F0AB16Q37341571-46B36E7E-6CCE-4396-9DFD-AA0A21B246B3Q37341817-1CD7E064-12C9-47DF-8B1F-E2A5463376E5
P2860
Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Association among plasma level ...... d subclinical atherosclerosis.
@en
Association among plasma level ...... d subclinical atherosclerosis.
@nl
type
label
Association among plasma level ...... d subclinical atherosclerosis.
@en
Association among plasma level ...... d subclinical atherosclerosis.
@nl
prefLabel
Association among plasma level ...... d subclinical atherosclerosis.
@en
Association among plasma level ...... d subclinical atherosclerosis.
@nl
P2093
P1476
Association among plasma level ...... d subclinical atherosclerosis.
@en
P2093
Amit Khera
Darren K McGuire
David A Morrow
James A de Lemos
Januario de P Meo Neto
Sabina A Murphy
P304
P356
10.1016/J.JACC.2004.07.047
P407
P577
2004-11-01T00:00:00Z